Related Experiment Videos

p53-dependent DNA damage-induced apoptosis requires Fas/APO-1-independent activation of CPP32beta

E J Fuchs1, K A McKenna, A Bedi

  • 1Johns Hopkins Oncology Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.

Cancer Research
|July 1, 1997
PubMed

Insights

p53 protein is crucial for DNA damage-induced apoptosis via CPP32beta (caspase 3) activation. Activating CPP32beta may treat p53-deficient cancers resistant to conventional therapies.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Biology

Background:

  • p53 tumor suppressor protein is essential for apoptosis induction by DNA damage.
  • Understanding p53-dependent cell death mechanisms is key for treating p53-deficient cancers.

Purpose of the Study:

  • To investigate if p53-dependent apoptosis requires CPP32beta (caspase 3) activation.
  • To explore the role of the Fas system in p53-dependent apoptosis.
  • To assess CPP32beta activation in p53-deficient cells.

Main Methods:

  • Irradiation of thymocytes and T cells.
  • Inhibition of CPP32beta using Ac-DEVD-CHO.
  • Fas ligation and CD3 stimulation.
  • Analysis of apoptosis in wild-type, p53-deficient, and Fas-deficient mice.

Main Results:

  • Irradiation-induced apoptosis showed p53-dependent CPP32beta activation.
  • CPP32beta inhibition protected normal thymocytes from irradiation-induced apoptosis.
  • p53-deficient thymocytes were sensitive to CPP32beta-mediated apoptosis induced by Fas or CD3 ligation.
  • DNA damage-induced apoptosis in T cells is p53-mediated and Fas-independent.

Conclusions:

  • p53-mediated activation of CPP32beta is essential for DNA damage-induced apoptosis in T cells.
  • This pathway is independent of Fas/FasL interactions.
  • Targeting CPP32beta may offer a therapeutic strategy for p53-deficient cancers resistant to standard treatments.

Related Concept Videos